LUNIVIA Trademark

Trademark Overview

On Thursday, November 3, 2011, a trademark application was filed for LUNIVIA with the United States Patent and Trademark Office. The USPTO has given the LUNIVIA trademark a serial number of 85463622. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 1, 2015. This trademark is owned by Sunovion Pharmaceuticals Inc.. The LUNIVIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances, namely, analgesics; anti-infectives; anti-inflammatories; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases of the central nervous system, peripheral nervous system, respiratory system, urogenital system, cardiovascular system, endocrine system, metabolic system, renal system, gastroenterologic system, ophthalmologic system, and dermatologic system; pharmaceutical preparations and substances for the prevention and treatment of hematologic and oncologic disorders and diseases, psychiatric disorders and diseases, allergic disorders and diseases and disorders and diseases of the immune system, connective tissue and joints; and pharmaceutical preparations and substances for the prevention and treatment of insomnia and other sleep related diseases and disorders; pharmaceutical preparations for the prevention and treatment of cancer
lunivia

General Information

Serial Number85463622
Word MarkLUNIVIA
Filing DateThursday, November 3, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 1, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 6, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances, namely, analgesics; anti-infectives; anti-inflammatories; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases of the central nervous system, peripheral nervous system, respiratory system, urogenital system, cardiovascular system, endocrine system, metabolic system, renal system, gastroenterologic system, ophthalmologic system, and dermatologic system; pharmaceutical preparations and substances for the prevention and treatment of hematologic and oncologic disorders and diseases, psychiatric disorders and diseases, allergic disorders and diseases and disorders and diseases of the immune system, connective tissue and joints; and pharmaceutical preparations and substances for the prevention and treatment of insomnia and other sleep related diseases and disorders; pharmaceutical preparations for the prevention and treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 7, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSunovion Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMarlborough, MA 01752
Party NameSunovion Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMarlborough, MA 01752

Trademark Events

Event DateEvent Description
Monday, June 1, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, June 1, 2015ABANDONMENT - NO USE STATEMENT FILED
Thursday, October 30, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 29, 2014EXTENSION 5 GRANTED
Monday, October 27, 2014EXTENSION 5 FILED
Monday, October 27, 2014TEAS EXTENSION RECEIVED
Saturday, May 3, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 2, 2014EXTENSION 4 GRANTED
Monday, April 28, 2014EXTENSION 4 FILED
Monday, April 28, 2014TEAS EXTENSION RECEIVED
Friday, November 8, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 7, 2013EXTENSION 3 GRANTED
Friday, November 1, 2013EXTENSION 3 FILED
Friday, November 1, 2013TEAS EXTENSION RECEIVED
Tuesday, July 16, 2013ASSIGNED TO EXAMINER
Saturday, May 4, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 3, 2013EXTENSION 2 GRANTED
Tuesday, April 30, 2013EXTENSION 2 FILED
Tuesday, April 30, 2013TEAS EXTENSION RECEIVED
Tuesday, November 6, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 5, 2012EXTENSION 1 GRANTED
Thursday, November 1, 2012EXTENSION 1 FILED
Monday, November 5, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, November 1, 2012TEAS EXTENSION RECEIVED
Friday, July 6, 2012ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 6, 2012TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 1, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 6, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 6, 2012PUBLISHED FOR OPPOSITION
Wednesday, February 15, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 1, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 1, 2012ASSIGNED TO LIE
Tuesday, January 17, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 13, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 12, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 12, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 6, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 6, 2012NON-FINAL ACTION E-MAILED
Friday, January 6, 2012NON-FINAL ACTION WRITTEN
Friday, January 6, 2012ASSIGNED TO EXAMINER
Monday, November 7, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, November 7, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

lunivia system disorders diseases pharmaceutical preparations treatment substances prevention nervous anti